CHO-CD36 Cells
2 622,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | Disclaimer: The prices displayed for cell lines are exclusively for academic/not-for-profit customers. For commercial entitites the price is approximately €6,250. CHO-CD36 cells are recombinant Chinese hamster ovary (CHO) cells engineered to stably express human CD36, a multifunctional class B scavenger receptor also known as platelet glycoprotein IV (GPIV) or fatty acid translocase (FAT). CD36 is broadly involved in lipid uptake, fatty acid metabolism, angiogenesis, inflammation, innate immunity, and cell adhesion. The receptor interacts with a wide range of ligands, including oxidized low-density lipoproteins (oxLDL), long-chain fatty acids, thrombospondin-1, phospholipids, and apoptotic cells. Dysregulated CD36 expression has been implicated in metabolic disorders, atherosclerosis, chronic inflammation, and tumor progression, making recombinant CD36-expressing cell models valuable tools for mechanistic and therapeutic research. CHO-CD36 cells are widely used for studying receptor-ligand interactions, lipid transport mechanisms, and therapeutic targeting of CD36-associated pathways. These cells support quantitative analysis of ligand binding, receptor internalization, fatty acid uptake, and downstream signaling events linked to oxidative stress, immune modulation, and metabolic adaptation. In oncology research, CHO-CD36 models are useful for investigating the role of CD36 in metastasis, tumor lipid metabolism, and resistance to metabolic stress. The cells are also applied in development and characterization of monoclonal antibodies, small-molecule inhibitors, lipid-targeting therapeutics, and imaging agents directed against CD36. Flow cytometry assays, uptake assays, and high-throughput screening platforms commonly utilize CHO-CD36 cells because of their stable and controlled recombinant receptor expression. |
|---|---|
| Organisme | Chinese hamster |
| Tissu | Ovary |
| Maladie | Chinese hamster ovary, non-neoplastic; genetically engineered for CD36 surface expression |
| Applications | Antibody screening; CD36-targeted therapy development; lipid metabolism research; scavenger receptor biology; flow cytometry |
Caractéristiques
| Âge | Adult |
|---|---|
| Genre | Female |
| Morphologie | Epithelial-like |
| Type de cellule | Epithelial cell of ovary |
| Propriétés de croissance | Adherent |
Données réglementaires
| Référence | CHO-CD36 (Cytion catalog number 305979) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 10029 |
| Cellosaurus - Numéro d'enregistrement | CVCL_8848 |
| Statut OGM | GMO-S1: This CHO cell line contains a CD36 expression cassette supporting receptor-function analyses. This classification applies only within Germany and may differ elsewhere. |
Données biomoléculaires
| Récepteurs exprimés | CD36 |
|---|
Manipulation
| Milieu de culture | For adherent cultures: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) For suspension cultures: CHO Growth Medium A (from InSCREENeX; InSCREENeX catalog number INS-ME-1039) |
|---|---|
| Suppléments | For adherent cultures: Supplement the medium with 5% FBS. Add Geneticin (G418-Sulfat) to achieve a final concentration of 0.5 mg/mL. |
| Réactif de dissociation | For adherent cultures: Trypsin-EDTA |
| Temps de doublement | approx. 14-16 hours |
| Repiquage | For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C for 5-10 minutes, or until the cells detach. Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days. |
| Rapport de fractionnement | 1 to 5 |
| Densité de semis | 2 to 5 x 104 cells/cm2 |
| Renouvellement des fluides | 2 to 3 times per week |
| Rétablissement après le dégel | After thawing, split the cells at a ratio of 1:2 to 1:3 in T25 flasks and allow the cells to recover from the freezing process and to adhere (for adherent cultures) for at least 24 hours. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|